Trending/Regenerative Medicine
Stem cell therapy furthers research for infants with hypoplastic left heart syndrome
ROCHESTER, Minn. ― A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative…
January 21, 2019
January 17, 2019
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community